View Older Stories View More Recent Stories

Jul 29, 2020 09:36PM Form 4 iTeos Therapeutics, Inc. For: Jul 28 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 29, 2020 09:00AM Piramal Pharma Solutions Announces Integrated Development Program with Bolt Biotherapeutics for Immune-Stimulating Antibody Conjugates and Sterile Fill-Finish
Jul 24, 2020 04:34PM Form SC 13D Nkarta, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 23, 2020 09:00PM Form 3 Inozyme Pharma, Inc. For: Jul 23 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 22, 2020 08:00AM Olema Oncology Announces $54 Million Series B Financing
Jul 17, 2020 07:55AM Verona Pharma plc (VRNA) Raises $200 Million in Oversubscribed Private Placement and Subscription
Jul 17, 2020 02:00AM Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
Jul 17, 2020 02:00AM Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
Jul 16, 2020 08:52PM Form 3 Pandion Therapeutics, For: Jul 16 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 13, 2020 02:21PM Vaxart (VXRT) Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility (Earlier)
Jul 13, 2020 01:34PM Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility
Jul 10, 2020 04:34PM Form SC 13G Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 10, 2020 04:30PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 10, 2020 04:25PM Form SC 13G/A Verastem, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 10, 2020 04:15PM Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Closing of $135.7 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option To Purc
Jul 9, 2020 08:58PM Form 3 Nkarta, Inc. For: Jul 09 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jul 8, 2020 12:38PM Therapeutics Acquisition Corp. (TXAC) Prices 11.8M Class A Share IPO at $10/Sh
Jul 8, 2020 12:25PM Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
Jul 7, 2020 07:00AM Vor Biopharma Closes $110 Million Series B Financing
Jul 1, 2020 08:30AM Bolt Biotherapeutics Closes $93.5 Million Series C Financing
Jun 26, 2020 12:00AM Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer
Jun 25, 2020 09:12PM Form 3 Akouos, Inc. For: Jun 25 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 25, 2020 05:02PM Form SC 13D Forma Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 22, 2020 09:52AM Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
Jun 22, 2020 09:52AM Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
Jun 18, 2020 09:26PM Form 3 Forma Therapeutics Holdi For: Jun 18 Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 16, 2020 08:00AM C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-Concept and to Advance Proprietary Platform
Jun 15, 2020 10:10AM Novavax (NVAX) Raises $200M from Private Placement with RA Capital
Jun 15, 2020 10:09AM Novavax to Raise $200 Million from Private Placement with RA Capital
Jun 15, 2020 10:09AM Novavax to Raise $200 Million from Private Placement with RA Capital
Jun 10, 2020 04:16PM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 4, 2020 08:15PM Everest Medicines Completes US$310 Million Series C Financing
May 29, 2020 08:00AM Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
May 29, 2020 08:00AM Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
May 28, 2020 04:05PM Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 28, 2020 04:05PM Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 26, 2020 09:00AM ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
May 26, 2020 08:00AM Vor Biopharma Adds to Leadership Team with Appointment of Chief Financial Officer
May 20, 2020 06:00AM Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
May 20, 2020 06:00AM Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
May 15, 2020 04:42PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 14, 2020 04:01PM Sutro Biopharma Announces Closing of $98.0 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
May 7, 2020 04:05PM Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress
May 6, 2020 07:06AM TG Therapeutics (TGTX) Announces $60M in ATM Offering
May 6, 2020 07:00AM TG Therapeutics Raises Approximately $60 Million in Gross Proceeds Through its At-the-Market Facility
Apr 28, 2020 08:31AM CANbridge Pharmaceuticals Appoints Acting Chief Scientific Officer
Apr 27, 2020 08:30AM Nkarta Therapeutics Appoints Two New Independent Directors
Apr 9, 2020 04:56PM Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 7, 2020 08:00AM Vor Biopharma Appoints Dr. Robert Pietrusko as Chief Regulatory and Quality Officer
Apr 1, 2020 12:06PM iTeos Therapeutics Closes $125 Million Series B2 Financing
View More Recent Stories View Older Stories